AKT1 and metabolic disease: The beneficial effects of CTRP1 are related to modulation of the activity of AMPK, AKT, and upregulation of leptin, suggesting CTRP1 may serve as a target in treating metabolic diseases, as well as the potential use of CTRP1 by gene transfer for the treatment of metabolic diseases.